SPECIFICITIES OF THERAPY-INDUCED ANTI-INTERFERON-ALPHA ANTIBODIES

被引:10
作者
BRAND, CM
LEADBEATER, L
机构
[1] Wellcome Research Laboratories, Beckenham, Kent BR3 3BS, Langley Court
来源
JOURNAL OF INTERFERON RESEARCH | 1994年 / 14卷 / 04期
关键词
D O I
10.1089/jir.1994.14.201
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
[No abstract available]
引用
收藏
页码:201 / 203
页数:3
相关论文
共 5 条
[1]   NEUTRALIZING ANTIBODIES TO INTERFERON-ALPHA - RELATIVE FREQUENCY IN PATIENTS TREATED WITH DIFFERENT INTERFERON PREPARATIONS [J].
ANTONELLI, G ;
CURRENTI, M ;
TURRIZIANI, O ;
DIANZANI, F .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (04) :882-885
[2]   ANTIBODIES DEVELOPING AGAINST A SINGLE RECOMBINANT INTERFERON PROTEIN MAY NEUTRALIZE MANY OTHER INTERFERON-ALPHA SUBTYPES [J].
BRAND, CM ;
LEADBEATER, L ;
BELLATI, G ;
MAROTTA, F ;
IDEO, G .
JOURNAL OF INTERFERON RESEARCH, 1993, 13 (02) :121-125
[3]  
GALTON JE, 1989, LANCET, V2, P572
[4]   LONG-TERM RESPONSE OF RECURRENT RESPIRATORY PAPILLOMATOSIS TO TREATMENT WITH LYMPHOBLASTOID INTERFERON ALFA-N1 [J].
LEVENTHAL, BG ;
KASHIMA, HK ;
MOUNTS, P ;
THURMOND, L ;
CHAPMAN, S ;
BUCKLEY, S ;
WOLD, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (09) :613-617
[5]  
WECK PK, 1989, J INTERFERON RES, V9, pS37